Clinical Trial Update: Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® [Phase 2]

View source ↗

Summary

Phase 2 study evaluating PR5I, a pediatric combination vaccine with an enhanced Hepatitis B component, given concomitantly with Prevnar; the trial has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Hepatitis B
• Pertussis
• Polio
• Tetanus

Drugs mentioned

• PR5I
• Prevnar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Pertussis | Phase 2 | Status: COMPLETED